Publication | Closed Access

Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding

ThrombopoiesisThrombosisAntiplatelet AntibodiesAutoimmune DiseaseBlood PlateletImmunologyHematologyPathologyPlatelet PathobiologyPlatelet AntagonistAutoimmunityMaipa AssayCoagulopathyImmunotherapyMedicineAnticoagulantAtherosclerosisImmune Thrombocytopenia